InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
前收盘价
US$14.30
+US$0.09 · +0.63%
盘后
US$14.4721
+US$0.1721 · +1.20%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
日内区间
当前US$14.30
52周区间
当前US$14.30
盘中时间采用ET。市场数据可能有所延迟。
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
日内区间
当前US$14.30
52周区间
当前US$14.30
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 3.7亿 USD | 3.95亿 USD | 4.92亿 USD | 4.54亿 USD | 3.58亿 USD |
| 销货成本 | 7952.5万 USD | 7775.2万 USD | 8070.8万 USD | 7348.5万 USD | 5359.2万 USD |
| 毛利 | 2.91亿 USD | 3.17亿 USD | 4.11亿 USD | 3.81亿 USD | 3.04亿 USD |
| 研究与开发 | 1331.9万 USD | 1313.7万 USD | 1341万 USD | 1242.5万 USD | 953.2万 USD |
| 销售、一般及管理费用 | 1.92亿 USD | 1.91亿 USD | 2.02亿 USD | 1.71亿 USD | 1.28亿 USD |
| 营业费用 | 2.06亿 USD | 2.05亿 USD | 2.16亿 USD | 1.83亿 USD | 1.36亿 USD |
| 利息收入 | 2494.3万 USD | 3093.8万 USD | 2160.7万 USD | 361.2万 USD | 52.5万 USD |
| 折旧和摊销 | 69.5万 USD | 72.8万 USD | 62.3万 USD | 68万 USD | 51.7万 USD |
| 营业利润 | 8538.7万 USD | 1.13亿 USD | 1.96亿 USD | 1.98亿 USD | 1.67亿 USD |
| 净利润 | 9383.1万 USD | 1.81亿 USD | 1.98亿 USD | 1.62亿 USD | 1.65亿 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$19.00
上涨空间 32.87%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2021年10月1日 | 2:1 | — | — |
已生效 2021年10月1日
2:1
报告持有此股票敞口的交易所交易基金。
iShares Core MSCI EAFE ETFIEFA791.47万0.00%1894.71亿 USD0.07%US$96.18-0.35%
iShares MSCI EAFE Small-Cap ETFSCZ244.59万0.02%128.85亿 USD0.40%US$83.62-0.37%
iShares Core MSCI Total International Stock ETFIXUS219.57万0.00%586.25亿 USD0.07%US$94.57-0.44%
ARK Israel Innovative Technology ETFIZRL198.98万1.52%1.34亿 USD0.49%US$27.9458-1.44%
Avantis International Small Cap Value ETFAVDV149.07万0.01%200.38亿 USD0.36%US$108.03-0.45%
iShares MSCI Israel ETFEIS144.66万0.17%8.6亿 USD0.59%US$116.94-1.13%
Schwab Fundamental International Small Company Index ETFFNDC142.4万0.05%30.73亿 USD0.39%US$49.50-0.48%
iShares Core MSCI International Developed Markets ETFIDEV141.68万0.00%331.28亿 USD0.04%US$89.01-0.22%
iShares Core MSCI EAFE ETFIEFA
iShares MSCI EAFE Small-Cap ETFSCZ
iShares Core MSCI Total International Stock ETFIXUS
ARK Israel Innovative Technology ETFIZRL
Avantis International Small Cap Value ETFAVDV
iShares MSCI Israel ETFEIS
Schwab Fundamental International Small Company Index ETFFNDC
iShares Core MSCI International Developed Markets ETFIDEVAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。